ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Oaktree Acquisition Corp

Oaktree Acquisition Corp (OAC)

16.38
0.00
(0.00%)
Closed December 13 4:00PM
0.00
0.00
(0.00%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
16.38
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
16.38
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
203,616,000
Dividend Yield
-
PE Ratio
-260.29
Earnings Per Share (EPS)
-0.12
Revenue
872M
Net Profit
-23.55M

About Oaktree Acquisition Corp

Sector
Offices Of Medical Doctors
Industry
Blank Checks
Website
Headquarters
Dover, Delaware, USA
Founded
2021

OAC Latest News

Hims & Hers Health, Inc. Closes Business Combination and Will Begin Trading on the New York Stock Exchange

Telehealth leader modernizing consumer-focused healthcare Hims & Hers Health, Inc. (“Hims & Hers”), a multi-specialty telehealth platform that connects consumers to licensed healthcare...

Market Recap and Looking Forward - Week of Jan 11th (GME, BTC, OAC, etc)

Tallahassee, FL -- January 15, 2021 -- InvestorsHub NewsWire -- via Investors Hub - Market Vision We quickly recap some significant events in the market, then chat about what is coming up...

Oaktree Acquisition Corp. Announces Extraordinary General Meeting Teleconference Details

Oaktree Acquisition Corp. (“OAC”) (NYSE: OAC), today announced that, due to the public health and safety concerns related to the coronavirus (COVID-19) pandemic and recommendations and orders...

Oaktree Acquisition Corp. Reminds Shareholders to Vote in Favor of the Business Combination with Hims & Hers

Oaktree Acquisition Corp. (NYSE: OAC.U, OAC, OAC WS) (“the Company”), a special purpose acquisition company sponsored by an affiliate of Oaktree Capital Management, L.P. (“Oaktree”), reminds its...

Hims & Hers Announces Q3 Update

Year-over-year Q3 revenue growth of 91% to $41.3 million Ended quarter with increase in gross margins to 76% as well as growth in net orders and average order value Company partnering with...

Hims & Hers, a Multi-Specialty Telehealth Platform, to Become Publicly-Traded via Merger with Oaktree Acquisition Corp.

Hims & Hers is a telehealth leader modernizing the delivery and accessibility of digital, consumer-focused healthcare services Transaction will enable further investment in growth and new...

Hims & Hers, a Multi-Specialty Telehealth Platform, to Become Publicly-Traded via Merger with Oaktree Acquisition Corp.

Hims & Hers is a telehealth leader modernizing the delivery and accessibility of digital, consumer-focused healthcare services Transaction will enable further investment in growth and new...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAMAA Mission Acquisition Corp
$ 10.07
(0.00%)
0
AACT.UAres Acquisition Corporation II
$ 10.8834
(0.00%)
0
AACTAres Acquisition Corporation II
$ 10.95
(0.00%)
0
AAAlcoa Corporation
$ 39.62
(0.00%)
0
AAgilent Technologies
$ 140.91
(0.00%)
0
AAMAA Mission Acquisition Corp
$ 10.07
(0.00%)
0
AACT.UAres Acquisition Corporation II
$ 10.8834
(0.00%)
0
AACTAres Acquisition Corporation II
$ 10.95
(0.00%)
0
AAAlcoa Corporation
$ 39.62
(0.00%)
0
AAgilent Technologies
$ 140.91
(0.00%)
0
AAMAA Mission Acquisition Corp
$ 10.07
(0.00%)
0
AACT.UAres Acquisition Corporation II
$ 10.8834
(0.00%)
0
AACTAres Acquisition Corporation II
$ 10.95
(0.00%)
0
AAAlcoa Corporation
$ 39.62
(0.00%)
0
AAgilent Technologies
$ 140.91
(0.00%)
0

OAC Discussion

View Posts
TallTrader TallTrader 4 years ago
Investor presentation

https://www.sec.gov/Archives/edgar/data/1773751/000119312520260568/d74354dex992.htm
👍️0
Nascarrat Nascarrat 4 years ago
But it does allow us to expand and grow into new businesses, too, including into big categories like sleep, infertility, diabetes and other chronic conditions.

TC: What about acquisitions?

AD: We’ll keep an eye open for strategic opportunities and consolidation opportunities. More than a dozen businesses a month come to us to be consolidated into the brand, but generally speaking, we’ve had the belief that so much is in front of us that we don’t want to be distracted.
👍️0
Nascarrat Nascarrat 4 years ago
As of last quarter, the business was growing 90% year-over-year, with 76% gross margins and greater cash efficiency, and that’s because as we provide more offerings, there is more cross-purchasing. Also, word of mouth is becoming more of a dynamic, with more than 50% of the traffic to the site free at this point because we have built a brand with a young demographic.
👍️0
Nascarrat Nascarrat 4 years ago
TC: You’re a Bay Area-based company selling to a mostly U.S. audience. How are you thinking about expanding that footprint geographically?

AD: We do have a small operation selling in the U.K.; we’re getting our feet wet in that market and building out a team and infrastructure and fulfillment. If you look at the regulatory landscape, there’s a huge amount of room [to grow] in Europe, Australia, Canada, the Middle East and Asia, and so in that order, we’ll start to [move into those markets].
👍️0
Nascarrat Nascarrat 4 years ago
On the contrary, Dudum says that while Hims might have once imagined a traditional IPO, it decided to go the special purpose acquisition company (SPAC) route because of their pricing mechanisms and because it was approached by a SPAC led by renowned money manager Howard Marks, the founder of the global alternative investment firm Oaktree Capital Management. (“We fell in love with the Oaktree team and the capital market experience and deep resources they have.”)
👍️0
OldJames OldJames 4 years ago
Steady climber
👍️0
Nascarrat Nascarrat 4 years ago
25 pre merger than big pop!
👍️0
Nascarrat Nascarrat 4 years ago
Pop to $25 upcoming
👍️0
Nascarrat Nascarrat 4 years ago
Loading up here!
👍️0
jalive jalive 4 years ago
Looking forward to January 19th voting. Giving a BIG OK for the Hims & Hers merger
👍️0
OldJames OldJames 4 years ago
nice. Gonna be a big mover post merger. I’m just sitting patiently and waiting.
👍️0
Nascarrat Nascarrat 4 years ago
Grabbing these 12.40ssss
👍️0
OldJames OldJames 4 years ago
Joined the party today
👍️0
OldJames OldJames 4 years ago
I don’t see warrants for this one, what’s the symbol? TIA
👍️0
ranchhand71 ranchhand71 4 years ago
buy the stock or warrants?
👍️0
Ecomike Ecomike 4 years ago
Good call in June on OAC.

It has done well.
👍️0
tyhub tyhub 4 years ago
In at 10.79.

Ty...
👍️0
freddie me freddie me 4 years ago
https://www.crunchbase.com/organization/hims
👍️0
freddie me freddie me 4 years ago
https://www.forhims.com/about
👍️0
freddie me freddie me 4 years ago
https://www.forhims.com/
👍️0
freddie me freddie me 4 years ago
https://www.bloomberg.com/news/articles/2020-08-07/hims-said-in-talks-to-go-public-via-oaktree-blank-check-company
👍️0
Golden Cross Golden Cross 4 years ago
$OAC waiting zone!
👍️0
paideia paideia 5 years ago
So, now the question up for discussion is... what is OAC going to be spending their $200MM on? And will the first acquisition raise the share price?
👍️0

Your Recent History

Delayed Upgrade Clock